Did you know that 85% of pharma companies face data challenges hindering the usage of advanced analytics in pricing and international referencing pricing? Yet, leveraging analytics when it comes to international reference pricing can help achieve a 3-10% boost in Return on Sales.
Watch our recording to uncover why the management of international reference pricing (IRP) at a new product launch but also post-launch is a must for pharmaceutical companies aiming to thrive in today’s market. Delve into how escalating healthcare costs, shifting regulations, and market access demands are reshaping the industry. Discover how our Simon-Kucher LS Genius | IRP tool can help you navigate these challenges, optimize pricing, and maintain a competitive edge.
Here’s what you’ll gain from our webinar recording:
- Global Regulatory Changes: Stay updated with the latest global market developments as countries worldwide revise their IRP policies. Understand the impact of increasing application of informal and less deterministic IRP rules.
- Complex pricing dynamics and IRP impact: Delve with us into the difficulty in managing prices across multiple countries simultaneously. We will discuss the challenges in balancing within-country revenue potential with the effects of international reference pricing (IRP) and why a multiple price metrics on list and net price level must be considered for a comprehensive global pricing strategy.
- Enhanced Analytics Utilization: Overcome IRP challenges by combining strategic perspective and advanced analytics in pricing. Get introduced to Simon-Kucher’s LS Genius | IRP – our tool for cross-country price and launch sequence optimization.
Don’t miss this opportunity to future-proof your business and lead the charge in pharma pricing.
